← Back to home

SEVERE COMBINED IMMUNODEFICIENCY T-CELL NEGATIVE B-CELL POSITIVE DUE TO JANUS KINASE-3 DEFICIENCY (DISORDER)

Clinical trials for SEVERE COMBINED IMMUNODEFICIENCY T-CELL NEGATIVE B-CELL POSITIVE DUE TO JANUS KINASE-3 DEFICIENCY (DISORDER) explained in plain language.

Never miss a new study

Get alerted when new SEVERE COMBINED IMMUNODEFICIENCY T-CELL NEGATIVE B-CELL POSITIVE DUE TO JANUS KINASE-3 DEFICIENCY (DISORDER) trials appear

Sign up with your email to follow new studies for SEVERE COMBINED IMMUNODEFICIENCY T-CELL NEGATIVE B-CELL POSITIVE DUE TO JANUS KINASE-3 DEFICIENCY (DISORDER), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Newborn screening study aims to catch rare diseases at birth

Diagnosis Ongoing

This study offers voluntary screening for newborns in North Carolina to detect a wide range of rare health conditions early. Using a small blood sample already collected at birth, the program tests for dozens of disorders, including spinal muscular atrophy, cystic fibrosis, and m…

Matched conditions: SEVERE COMBINED IMMUNODEFICIENCY T-CELL NEGATIVE B-CELL POSITIVE DUE TO JANUS KINASE-3 DEFICIENCY (DISORDER)

Sponsor: RTI International • Aim: Diagnosis

Last updated Jul 01, 2026 23:00 UTC

SEVERE COMBINED IMMUNODEFICIENCY T-CELL NEGATIVE B-CELL POSITIVE DUE TO JANUS KINASE-3 DEFICIENCY (DISORDER)

Get alerted when new SEVERE COMBINED IMMUNODEFICIENCY T-CELL NEGATIVE B-CELL POSITIVE DUE TO JANUS KINASE-3 DEFICIENCY (DISORDER) trials appear

Newborn screening study aims to catch rare diseases at birth